216 related articles for article (PubMed ID: 33357026)
21. Gaps in evidence in the management of patients with intermediate-risk pulmonary arterial hypertension: Considerations following the ESC/ERS 2022 guidelines.
D'Alto M; Badagliacca R; Airò E; Ameri P; Argiento P; Garascia A; Lombardi CM; Mulè M; Raineri C; Scelsi L; Vizza CD; Ghio S
Vascul Pharmacol; 2024 Jun; 155():107374. PubMed ID: 38642596
[TBL] [Abstract][Full Text] [Related]
22. Pulmonary Arterial Hypertension: a Pharmacotherapeutic Update.
Coons JC; Pogue K; Kolodziej AR; Hirsch GA; George MP
Curr Cardiol Rep; 2019 Nov; 21(11):141. PubMed ID: 31758342
[TBL] [Abstract][Full Text] [Related]
23. Successful management of two pregnant patients with idiopathic pulmonary arterial hypertension.
Gerede DM; Acıbuca A; Vurgun VK; Sayın T; Erol C
Int J Cardiol; 2015 Feb; 180():72-3. PubMed ID: 25438217
[No Abstract] [Full Text] [Related]
24. Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances.
Maron BA; Abman SH; Elliott CG; Frantz RP; Hopper RK; Horn EM; Nicolls MR; Shlobin OA; Shah SJ; Kovacs G; Olschewski H; Rosenzweig EB
Am J Respir Crit Care Med; 2021 Jun; 203(12):1472-1487. PubMed ID: 33861689
[TBL] [Abstract][Full Text] [Related]
25. The right ventricle tamed.
de Man FS; Vonk Noordegraaf A
Eur Respir J; 2023 May; 61(5):. PubMed ID: 37208035
[No Abstract] [Full Text] [Related]
26. Pulmonary Arterial Hypertension.
Hassoun PM
N Engl J Med; 2021 Dec; 385(25):2361-2376. PubMed ID: 34910865
[No Abstract] [Full Text] [Related]
27. Distensibility, an Early Disease Marker of Pulmonary Vascular Health: Ready for Clinical Application.
Raza F; Chesler NC
J Am Heart Assoc; 2023 Oct; 12(20):e031605. PubMed ID: 37815032
[No Abstract] [Full Text] [Related]
28. [Successful pregnancy in a patient with idiopathic pulmonary arterial hypertension. Case report].
Szenczi O; Karlócai K; Bucsek L; Rigó J
Orv Hetil; 2016 Apr; 157(15):593-5. PubMed ID: 27039998
[TBL] [Abstract][Full Text] [Related]
29. Interdependence of hypoxia and β-adrenergic receptor signaling in pulmonary arterial hypertension.
Stephens OR; Weiss K; Frimel M; Rose JA; Sun Y; Asosingh K; Farha S; Highland KB; Prasad SVN; Erzurum SC
Am J Physiol Lung Cell Mol Physiol; 2019 Sep; 317(3):L369-L380. PubMed ID: 31242023
[TBL] [Abstract][Full Text] [Related]
30. Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
Singh N; Ventetuolo CE
Am J Respir Crit Care Med; 2022 May; 205(9):988-990. PubMed ID: 35143371
[No Abstract] [Full Text] [Related]
31. The Pursuit of Risk Assessment and Stratification Tools in Pulmonary Arterial Hypertension: Have We Seen the Lite?
Ford HJ; LeVarge B
Chest; 2021 Jan; 159(1):14-16. PubMed ID: 33422195
[No Abstract] [Full Text] [Related]
32. [Diagnosis and therapy of pulmonary arterial hypertension].
Pizarro C; Nickenig G; Skowasch D
Dtsch Med Wochenschr; 2023 Nov; 148(23):1491-1497. PubMed ID: 37949077
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary arterial hypertension in pregnancy.
Običan SG; Cleary KL
Semin Perinatol; 2014 Aug; 38(5):289-94. PubMed ID: 25037519
[TBL] [Abstract][Full Text] [Related]
34. Against the Odds: Risk Stratification with Cardiac Magnetic Resonance Imaging in Pulmonary Arterial Hypertension.
Richter MJ; Tello K
Am J Respir Crit Care Med; 2020 Feb; 201(4):403-405. PubMed ID: 31726011
[No Abstract] [Full Text] [Related]
35. [Risk stratification methods and their significance in pulmonary arterial hypertension].
Avdeev SN; Tsareva NA
Ter Arkh; 2019 Sep; 91(9):150-157. PubMed ID: 32598827
[TBL] [Abstract][Full Text] [Related]
36. Genotypes and Phenotypes of Chinese Pediatric Patients With Idiopathic and Heritable Pulmonary Arterial Hypertension-A Single-Center Study.
Zhang HS; Liu Q; Piao CM; Zhu Y; Li QQ; Du J; Gu H
Can J Cardiol; 2019 Dec; 35(12):1851-1856. PubMed ID: 31813511
[TBL] [Abstract][Full Text] [Related]
37. Risk Stratification in Pulmonary Arterial Hypertension: Perhaps Simple Is Not Best?
Fauvel C; White RJ; Vanderpool RR; Badagliacca R; Tobore T; Rahman M; Vizza CD; Lin S; Everett AD; Visovatti SH; Benza RL
Chest; 2024 Feb; 165(2):431-436. PubMed ID: 37709252
[No Abstract] [Full Text] [Related]
38. Continued Progress in Therapy for Pulmonary Arterial Hypertension.
Taichman DB; Leopold JA; Elliott G
N Engl J Med; 2023 Apr; 388(16):1524-1526. PubMed ID: 36876747
[No Abstract] [Full Text] [Related]
39. The importance of right ventricular evaluation in risk assessment and therapeutic strategies: Raising the bar in pulmonary arterial hypertension.
Badagliacca R; Papa S; Matsubara H; Lang IM; Poscia R; Manzi G; Vizza CD
Int J Cardiol; 2020 Feb; 301():183-189. PubMed ID: 31806280
[TBL] [Abstract][Full Text] [Related]
40. Guideline implementation and early risk assessment in pulmonary arterial hypertension associated with congenital heart disease: A retrospective cohort study.
Deng X; Jin B; Li S; Li Y; Zhou H; Wu Y; Yan M; Hu Y; Qiu Q; Zhang G; Zheng X
Clin Respir J; 2019 Nov; 13(11):693-699. PubMed ID: 31419027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
